MedTrace Logo

The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients

NCT01487473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2014-02-13

No results posted yet for this study

Summary

The main purpose of this study is to determine the degree to which Mindfulness-Based Stress Reduction, a group-based psychological therapy that includes mindfulness meditation exercises, reduces depression, anxiety, stress, pain intensity, and interference of pain with daily life among adult chronic pain patients.

The second purpose is to examine the role of attention in improving psychological and physical health for chronic pain patients.

Conditions

Interventions

BEHAVIORAL

Mindfulness-Based Stress Reduction

An 8-week structured group program that was developed to improve psychological and physical symptoms associated with pain. It incorporates a variety of mindfulness meditation exercises including mindful yoga, sitting meditation, and body scan to facilitate attention, acceptance, and awareness of one's experiences.

Sponsors & Collaborators

  • Mount Sinai Hospital, Canada

    collaborator OTHER

  • Wasser Pain Management Centre

    collaborator UNKNOWN

  • Rasch Foundation

    collaborator UNKNOWN

  • York University

    lead OTHER

Principal Investigators

  • Nicholas Cepeda, PhD · York University

  • Allan Gordon, MD · MOUNT SINAI HOSPITAL

  • Denise Paneduro, PhD student · York University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487473 on ClinicalTrials.gov